英文論文（2026年）

    1. Fukutsu K, Murata M, Kikuchi K, Noda K, Ishida S. Acrolein Promotes Retinal Inflammation Through Macrophage Chemotaxis by Inducing CCL2 Production From Müller Cells. FASEB J. 2026; 40: e71403
    2. Gonzalez G, Nao N, Tabata K, Itakura Y, Saito S, Takahashi K, Kobayashi M, Kitaichi N, Ishiguro N, Fujimoto T, Kajon AE, Sawa H, Hanaoka N. Tiled-amplicon whole-genome sequencing methods reveals endemic circulation of human adenovirus type 3 in Japan. Viruses. 2026; 18: 74
    3. Kitaichi N, Delizo K, Dei R, Yoshikawa I, Suzuki K, Nitta A, Kataoka Y, Nakajima K. A Machine Learning-Based Fall Risk Prediction Model for Parkinson's Disease Considering Ophthalmic Disorders. Parkinsonism Relat Disord. 2026; 147: 108306
    4. Le Yi Wong J, Cheng H, Peh WJ, Ho D, Wong TY, Hui CYY, Ting DSJ, Bee YM, Goh SY, Apte RS, Mahajan VB, Goldberg JL, Bischof E, Sinclair DA, Cheung CC, Chan HH, Fukutsu K, Tan TF, Quek CWN, Hong ASY, Jin LY, Wagner SK, Keane P, Ferrara D, Eydelman M, Lam DSC, Wang X, Ting DSW. Oculomics and AI: The eye as a biomarker for health span. Asia Pac J Ophthalmol. 2026; 15: 100282
    5. Pulido JS, Mano F, Casella M, Ishida S. Infectious retinitis associated with JAK inhibitors: the ongoing duality of JAK inhibitors. Int J Retina Vitr. 2026; 12: 40
    6. Saito M, Mitamura M, Ito Y, Endo H, Katsuta S, Ishida S. A deep learning-based pachychoroid index based on choroidal image patterns of central serous chorioretinopathy using enhanced-depth-imaging optical coherence tomography. Jpn J Ophthalmol. 2026; 70: 589-597
    7. Suzuki K, Iwata D, Namba K, Hase K, Hiraoka M, Murata M, Kitaichi N, Ohno S, Ishida S. The Role of Plasminogen Activator Inhibitor -1 in Uveitis: Findings from Clinical and Experimental Studies. Curr Eye Res. 2026; 51: 788-795
    8. Mitamura S, Oide S, Sasaki Y, Idogawa H, Mitamura M, Kanno-Okada H, Osawa M, Maeda T. Giant Pleomorphic Adenoma of the Lacrimal Sac Initially Suspected to Represent a Sinonasal Malignancy 16 Years After Dacryocystorhinostomy. Diagnostics. 2026; 16: 2027
    9. Wada I, Ishikawa K, Yamaguchi M, Shimokawa S, Rui J, Mori K, Kaizu Y, Arima M, Notomi S, Murakami Y, Inagaki S, Kohro Y, Tsuda M, Shibata K, Terao R, Terabayashi T, Ishizaki T, Yoshida S, Ishibashi T, Ishida S, Apte RS, Sonoda KH, Nakao S. RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMD. Invest Ophthalmol Vis Sci. 2026; 67: 33
    10. Wakabayashi A, Namba K, Iwata D, Mizuuchi K, Hase K, Suzuki K, Ogino Y, Hiraoka M, Kitaichi N, Takeyama S, Atsumi T, Ishida S. A Case of Refractory Panuveitis withCoexisting Spondyloarthritis Successfully Treated with Tofacitinib. Case Rep Ophthalmol. 2026; 17: 281-288
    11. Zheng F, Motulsky E, Roisman L, Fang X, Fukutsu K, Wong CW, Barathi VA, Wong E, Tsai ASH, Kim LA, Tan GS. Advancing perspectives on proliferative vitreoretinopathy: Updates in experimental research and emerging clinical treatments. Asia Pac J Ophthalmol. 2026; 15: 100302
    12. Sugihara Y, Takamura Y, Yamada Y, Morioka M, Gozawa M, Kato K, Hirano T, Murao F, Shimizu M, Kusuhara S, Murakami T, Takenaka Y, Okabe N, Jujo T, Terasaki H, Nagasato D, Dong Z, Yoshida S, Ogura S, Yasuda K, Ishigooka G, Sawada O, Higashijima F, Inatani M. Characterization of the visually impaired patients with diabetes mellitus in Japan. J Diabetes Investig. 2024; 15: 882-891 (2024年記載漏れ)
    13. Yao J, Hong ASY, Fukutsu K, Ting DSW. Artificial intelligence oculomics for systemic health and longevity medicine: 2025 and beyond. Curr Opin Ophthalmol. 2025; 36: 477–486 (2025年記載漏れ)